|
Code
|
44440
|
|
MA number
|
59/0298/07-S
|
|
Product Form:
|
plv iol 10+10x0,5 ml solv. (liek.inj.skl.+striek.skl.napl.+2 ihly)
|
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
|
Type of procedure:
|
Mutual recognition procedure
|
|
MAH, country:
|
GlaxoSmithKline Biologicals S.A., Belgium
|
|
Therapeutic Class:
|
59 - IMMUNOPRAEPARATA
|
|
ATC:
|
| J |
ANTIINFECTIVES FOR SYSTEMIC USE |
| J07 |
VACCINES |
| J07B |
VIRAL VACCINES |
| J07BD |
Measles vaccines (old: Morbilli vaccines) |
| J07BD54 |
Measles, combinations with mumps, rubella and varicella, live attenuated |
|
|
Shelf life:
|
18 |
|
Container:
|
vial glass and pre-filled syringe glass
|
|
Route of admin.:
|
Subcutaneous and intramuscular use
|
SPC_Priorix-Tetra_09.2025.pdf
